Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.820
-0.080 (-2.05%)
At close: Aug 7, 2026, 4:00 PM EDT
3.890
+0.070 (1.83%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $20.65 million as of August 7, 2026. Its market cap has increased by 40.07% in one year.
Market Cap
20.65M
Enterprise Value
1.24M
1-Year Change
40.07%
Ranking
Category
Stock Price
$3.82
ChartMarket Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $20.65M, an increase of 91.36%. That is a compound annual growth rate of 49.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 20.65M | -1.05% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 22.08M |
| Polyrizon | 21.69M |
| NextCure | 21.09M |
| Daré Bioscience | 20.97M |
| Cellectar Biosciences | 20.54M |
| Cocrystal Pharma | 20.42M |
| Atossa Therapeutics | 20.32M |
| Celularity | 20.28M |